Sandra Levy
ARTICLES BY THIS AUTHOR
- 9/14/2021
Upsher-Smith partners with Cove to expand access to Tosymra for migraine
Upsher-Smith's migraine medication Tosymra will now be offered through Cove's telemedicine platform. - 9/14/2021
CVS Caremark launches new efforts to tackle health disparities
CVS Caremark is expanding its efforts to address systemic inequities with a long-term, collaborative focus on community-based programs for patients with serious chronic illnesses. - 9/13/2021
AAM makes 2 key appointments
The organization is welcoming Polly Webster as vice president of federal affairs and Erik Komendant as senior vice president of government affairs. - 9/13/2021
First look: Hy-Vee opens state-of-the-art store in Grimes, Iowa
The 93,000-sq.-ft. store features Hy-Vee’s newest technology, innovations and partnerships. - 9/13/2021
UCI to welcome inaugural Pharm.D. class with white coat ceremony
Pharm.D. students at the University of California, Irvine will mark the start of their education on Sept. 24. - 9/13/2021
Sandoz enters agreement with Bio-Thera Solutions for Avastin biosimilar
Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that targets vascular endothelial growth factor, a key mediator of angiogenesis in cancer. - 9/13/2021
Amber Specialty Pharmacy, Hy-Vee Pharmacy Solutions to administer Regeneron monoclonal antibody treatment
Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions have 21 locations in the United States and Puerto Rico that are licensed to administer Regeneron’s monoclonal antibody treatment. - 9/2/2021
FDA gives BeiGene green light for new Brukinsa indication
BeiGene's Brukinsa is now FDA approved for the treatment of adult patients with Waldenström’s macroglobulinemia. - 9/2/2021
FDA OKs Impel NeuroPharma's Trudhesa
Trudhesa is a nasal spray used for the acute treatment of migraine with or without aura in adults. - 9/1/2021
AMA, APhA and AHSP: Stop using ivermectin to treat, prevent COVID-19 outside of clinical trials
The three organizations issued a statement saying they oppose ordering, prescribing and dispensing ivermectin to prevent or treat COVID-19 outside the context of a clinical trial.
